Ads
related to: anxiety disorder
Search results
Everything Cyclists Need to Know About Balancing Glucose Levels
Bicycling Magazine· 6 days agoOriginally developed to help people manage glucose dysregulation conditions such as type 1 and type...
Tonix Pharmaceuticals Receives Rare Pediatric Disease Designation from the FDA for TNX-2900 for the...
Morningstar· 3 days agoTNX-2900 is a proprietary magnesium-potentiated formulation of intranasal oxytocin, a naturally occurring hormone that reduces appetite and eating Prader Willi syndrome is the most common genetic cause of life-threatening childhood obesity CHATHAM
OC jail workers not negligent in the suicide of former columnist’s son, DA says
Orange County Register· 7 days agoThe Orange County district attorney’s office has concluded that jail personnel were not negligent in...
Jarvis: Biden’s $12 billion for women’s health should be just a start
The Santa Rosa Press Democrat· 4 days agoFor example, one analysis found that conditions that overwhelmingly affect women, like migraines,...
Column: Biden's $12 billion for women's health should be just a start
Yakima Herald-Republic· 2 days agoFor example, one analysis found that conditions that overwhelmingly affect women, like migraines,...
‘It’s nearly impossible to orient yourself’ - How hoarding impacts firefighters
KCRG-TV9 Cedar Rapids· 2 days agoWhile new technology and gear have made firefighters’ jobs safer over the years, it still comes with...
Robert Barrow Sells 16,519 Shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Stock
ETF DAILY NEWS· 14 hours agoMind Medicine (MindMed) Inc. (NASDAQ:MNMD – Get Free Report) CEO Robert Barrow sold 16,519 shares of the business’s stock in a transaction dated Monday, March 25th. The stock was sold at an ...
Dear Annie: My husband’s hypochondria is out of hand
Anchorage Daily News· 7 days agoAdvice from Annie Lane.
Committee on Children 2024 annual report released
WLTX-TV Columbia· 7 days agoThe South Carolina Committee on Children unveiled its annual report on Thursday, spotlighting critical issues affecting children, including sex...
Protagenic Therapeutics Successfully Concludes Third Cohort in Single Dose Portion of Phase 1 Trial...
Morningstar· 1 day agoNext clinical progress update expected in April 2024NEW YORK, NY / ACCESSWIRE / March 27, 2024 / Protagenic Therapeutics, Inc. (NASDAQ:PTIX), a leader in biopharmaceutical innovation, advances ...